Applied DNA Sciences (NASDAQ:APDN ) | WebDisclosure

Basculer en Français

8623	Companies
143123	Keywords
78872	Articles
76497	Press releases

Home
Companies
Applied DNA Sciences

PRESS RELEASE

published on 01/08/2025 at 22:30, 3 months 13 days ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
Applied DNA Sciences reschedules Investor Update call to February 13, 2025, coinciding with Q1 fiscal 2025 results release due to National Day of Mourning. Company develops PCR-based technologies

Financial Results Applied DNA Sciences Investor Update PCR-based Technologies Rescheduled Call
BRIEF

published on 12/18/2024 at 15:05, 4 months 4 days ago

Linea DNA d'Applied DNA obtient l'approbation pour un essai clinique sur la thérapie par cellules CAR-T

Essai Clinique ADN Appliqué Ligne ADN Thérapie Par Cellules CAR-T Traitement De La LAM
BRIEF

published on 12/18/2024 at 15:05, 4 months 4 days ago

Applied DNA's Linea DNA Gains Approval for Clinical Trial in CAR T-Cell Therapy

Clinical Trial Linea DNA CAR T-cell Therapy AML Treatment Applied DNA
PRESS RELEASE

published on 12/18/2024 at 15:00, 4 months 4 days ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
Regulatory approval for Phase I clinical trial of CD123-specific autologous CAR T-cell therapy by UHKT showcases Linea DNA as a rapid and cost-efficient manufacturing solution for AML treatment

Regulatory Approval Clinical Trial Linea DNA AML Treatment CAR-T Cell Therapies
BRIEF

published on 12/17/2024 at 22:10, 4 months 4 days ago

Applied DNA Sciences publie ses résultats pour l'exercice 2024 et annonce une restructuration stratégique

Restructuration Stratégique Résultats Financiers 2024 ADN Appliqué Fabrication GMP Médicaments Génétiques
BRIEF

published on 12/17/2024 at 22:10, 4 months 4 days ago

Applied DNA Sciences Reports FY2024 Results and Announces Strategic Restructuring

Strategic Restructuring GMP Manufacturing Applied DNA Fiscal Results 2024 Genetic Medicines
PRESS RELEASE

published on 12/17/2024 at 22:05, 4 months 4 days ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Applied DNA Sciences, Inc. reports financial results for Q4 FY2024 and announces strategic restructuring with focus on genetic medicines. Completes GMP manufacturing facility by Jan 9, 2025

Financial Results Applied DNA Sciences Strategic Restructuring GMP Manufacturing Facility Genetic Medicines
BRIEF

published on 12/16/2024 at 16:05, 4 months 6 days ago

Applied DNA to Announce Financial Results and Provide Facility Update

Financial Results Conference Call Webcast Applied DNA GMP Facility
BRIEF

published on 12/16/2024 at 16:05, 4 months 6 days ago

Applied DNA annonce ses résultats financiers et fournit une mise à jour sur ses installations

Résultats Financiers Webcast Conférence Téléphonique ADN Appliqué Installation GMP
PRESS RELEASE

published on 12/16/2024 at 16:00, 4 months 6 days ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Applied DNA Sciences, Inc. to release Q4 and FY 2024 financial results on Dec 17, 2024, and host conference call on Jan 9, 2025, discussing GMP manufacturing facility

Financial Results Conference Call Applied DNA Sciences PCR-based Technologies GMP Manufacturing Facility

Accesswire

Published on 04/22/2025 at 15:45, 3 hours 27 minutes ago

Alaska Energy Metals Files Updated NI 43-101 Technical Report for The Eureka Deposit, Nikolai Nickel Project, Alaska, USA
Published on 04/22/2025 at 15:15, 3 hours 57 minutes ago

Silver Bull Announces Voting Results of Annual Meeting of Shareholders
Published on 04/22/2025 at 15:15, 3 hours 57 minutes ago

D. Boral Capital Acted as Exclusive Placement Agent to Safe & Green Holdings Corp. (Nasdaq: SGBX) in Connection with Its Approximately $8.0 Million Private Placement
Published on 04/22/2025 at 15:00, 4 hours 12 minutes ago

BlackBerry Earns FedRAMP High Authorization for Crisis Communication Software
Published on 04/22/2025 at 15:00, 4 hours 12 minutes ago

Vox Royalty Notes Production and Development Milestones on Western Australia Gold Royalty Assets

View all ACCESSWIRE

EQS Group

Published on 04/22/2025 at 19:00, 12 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 AVRIL 2025 au 18 AVRIL 2025
Published on 04/22/2025 at 18:35, 36 minutes ago

Bilfinger SE: Share Buyback
Published on 04/22/2025 at 17:57, 1 hour 14 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/22/2025 at 17:35, 1 hour 37 minutes ago

STEICO SE: Q1 2025 – solid growth despite strained construction sector
Published on 04/22/2025 at 16:52, 2 hours 19 minutes ago

Dalata Hotel Group PLC: HOL-Holding(s) in Company*

Les Echos

Published on 04/22/2025 at 18:13, 58 minutes ago

ELECTRICITE DE STRASBOURG - Droits de vote au jour de l'avis de réunion de l'AGO du 14 mai 2025
Published on 04/22/2025 at 18:12, 59 minutes ago

ELECTRICITE DE STRASBOURG - Avis de mise à disposition des rapports 2024, des rapports des CAC et des états financiers
Published on 04/22/2025 at 18:00, 1 hour 12 minutes ago

RA 2024
Published on 04/22/2025 at 17:57, 1 hour 14 minutes ago

NRJ Group - AGM 15 mai 2025 - Mise à disposition des documents préparatoires
Published on 04/22/2025 at 17:57, 1 hour 14 minutes ago

Annual Shareholders' Meeting 2025 - Conditions of availability of the preparatory documents

View all LES ECHOS COMFI WIRE